Healthy Subjects Clinical Trial
— PI19/00507Official title:
Target Mitochondrial Fitness, Chronobiology and Metabolism
Exercise could be an element that affects the biochemical, metabolic and microbiome parameters of organisms. Thus, to identify and validate the effects of aerobic and anaerobic exercises at different times of the day (morning or afternoon) on mitochondrial fitness and whether this changes could have a relation with metabolism and cardiovascular parameters and microbiome is of great interest for its applicability in biomedicine. As specific objectives of this project will study: 1. - To study the direct effect of aerobic and anaerobic exercise at different time points in the day on mitochondria fitness (short study: basal, at the end of the exercise and 2 h after exercise). 2. - To study mitochondria fitness under morning or afternoon aerobic and anaerobic exercise (prospective study: basal, 4, 8 and 12 weeks of the study). 3. - To identify and validate modulators and target proteins of mitochondria fitness affected by exercise (miRNA omic and proteomic analysis of mitochondria from the different groups of the study at basal and 12 weeks of the study). 4. - To study the relationship of the mitochondrial response (Objectives 1 and 2) to the different combination of exercises and chronobiology with anthropometric-clinical, carbohydrate and lipid metabolic and cardiovascular changes. 5. - To check the effect of morning or afternoon aerobic and anaerobic exercise on gut microbiota and its relation to mitochondria fitness, clinical and metabolic parameters (basal, 4, 8 and 12 weeks of the study).
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | December 31, 2023 |
Est. primary completion date | July 29, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 55 Years |
Eligibility | Inclusion Criteria: - 20- - IMC <30 kg/m2 - Informed consent Exclusion Criteria: - Smoker - Previous physical exercise of more than 20 minutes / 2 times a week |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Universitario Virgen de la Victoria | Málaga |
Lead Sponsor | Collaborator |
---|---|
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in weight | Weight in kg | From baseline to week 12 | |
Primary | BMI (body mass index) changes | Measured by body composition analysis | From baseline to week 12 | |
Primary | Change in waist circumference | Circumference in cm | From baseline to week 12 | |
Primary | Change in hip circumference | Circumference in cm | From baseline to week 12 | |
Primary | Changes in diastolic and systolic blood pressure | To analyze the effect of exercise on blood pressure | From baseline to week 12 | |
Primary | Changes in body composition | To analyze the effect of exercise on anthropometric parameters measured by bioelectrical impedance analysis | From baseline to week 12 | |
Primary | Change in glucose concentration | Glucose in mg/dl | From baseline to week 12 | |
Primary | Change in insulin concentration | Insulin in mg/dl | From baseline to week 12 | |
Primary | Change in glycated haemoglobin concentration | Glycated haemoglobin in mg/dl | From baseline to week 12 | |
Primary | Change in Triglycerides concentration | Triglycerides in mg/dl | From baseline to week 12 | |
Primary | Change in cholesterol concentration | Serum cholesterol in mg/dl | From baseline to week 12 | |
Primary | Change in HDL concentration | Serum HDL in mg/dl | From baseline to week 12 | |
Primary | Change in LDL concentration | Serum LDL in mg/dl | From baseline to week 12 | |
Primary | Change in transaminases concentration | Serum transaminases in UI/l | From baseline to week 12 | |
Primary | Change in creatinine concentration | Creatinine in mg/dl | From baseline to week 12 | |
Primary | Change in uric acid concentration | Uric acid in mg/dl | From baseline to week 12 | |
Primary | Change in alkaline phosphatase concentration | Serum alkaline phosphatase in UI/l | From baseline to week 12 | |
Primary | Change in bilirubin concentration | Serum bilirubin in mg/dl | From baseline to week 12 | |
Primary | Change in lactate concentration | Serum lactate in mmol/L | From baseline to week 12 | |
Primary | Change in cortisol concentration | Serum cortisol in nmol/L | From baseline to week 12 | |
Primary | Change in total and free testosterone concentration | Serum total and free testosterone in nmol/L | From baseline to week 12 | |
Primary | Change in melatonine concentration | Serum melatonine in pg/ml | From baseline to week 12 | |
Primary | Characterize exercise participant behavior | International Physical Activity Questionnaire (IPAQ). The IPAQ consists of 7 questions about the frequency, duration and intensity of activity (moderate and intense) carried out in the last seven days, as well as walking and sitting time in a work day. It evaluates three characteristics of physics (PA): intensity (mild, moderate or vigorous), frequency (days per week) and duration (time per day). Weekly activity is recorded in Mets (Metabolic Equivalent of Task or Metabolic Index Units) per minute and week. | From baseline to week 12 | |
Primary | Mediterranean diet adherence questionnaire | To evaluate adherence to a Mediterranean diet pattern. It consists of 14 items in which different components of the Mediterranean diet are evaluated (number of pieces of fruit consumed per day, number of portions of legumes consumed per week...). Each item is scored as 0 or 1. A total score of <9 indicates poor adherence, while a score of =9 indicates good adherence. | From baseline to week 12 | |
Primary | Change in faecal microbiota | To evaluate faecal microbiota composition in the studied subjects and the effect of aerobic and anaerobic exercise in the morning or afternoon on faecal microbiota composition. 16S rRNA amplicons of fecal community DNA | From baseline to week 12 | |
Primary | Change in fitness mitochondrial | To evaluate the effect of aerobic and anaerobic exercise in the morning or afternoon on mitochondrial fitness, evaluated by mitochondrial gene expression and protein abundance, mitochondrial metabolites, mitochondrial markers trough flow citometry. | From baseline to week 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05483998 -
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT02235012 -
Cognitive Biases Under Ketamine
|
N/A | |
Recruiting |
NCT02417714 -
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
|
||
Completed |
NCT05088343 -
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04418973 -
Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject.
|
N/A | |
Not yet recruiting |
NCT06248801 -
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
|
Phase 1 | |
Terminated |
NCT04068259 -
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03279302 -
Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06233162 -
Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets
|
Phase 1 | |
Recruiting |
NCT04159844 -
Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects
|
N/A | |
Completed |
NCT06137911 -
Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.
|
Phase 1 | |
Completed |
NCT04849286 -
Measurement of HTL0016878 in Cerebrospinal Fluid
|
Phase 1 | |
Not yet recruiting |
NCT06233227 -
Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule
|
Phase 1 | |
Completed |
NCT04096157 -
A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants
|
Phase 1 | |
Completed |
NCT01200368 -
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
|
Phase 3 | |
Recruiting |
NCT05805033 -
Peri-Implant Soft Tissue Integration in Humans: Influence of Material
|
N/A | |
Completed |
NCT04027803 -
Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®
|
Phase 1 | |
Recruiting |
NCT03467880 -
Multicenter Study of Impulse Oscillometry in Chinese
|
N/A | |
Completed |
NCT02903095 -
Single Ascending Dose Study of TD-1439 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT02341508 -
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
|
Phase 1 |